LEO Pharma announced the appointment of Nathalie Daste as new Executive Vice President, Global People and Corporate Affairs, and member of its Global Leadership Team, effective October 1, 2023.
Nathalie Daste brings extensive experience in organization design, transformation and capability building in the healthcare sector. Over the past decade, she has led a number of large-scale initiatives focused on building a distinctive culture and driving organizational performance for large companies in the pharma and industrial sectors. Nathalie has a proven track record at a global level at Novartis and McKinsey & Company where she started her career. She was recently Chief People Officer, Global Head Strategy & Commercial Excellence at CENTOGENE .
In her new role, Nathalie Daste will head LEO Pharma’s Global People function as well as Corporate Affairs, including sustainability and ESG. She succeeds Dennis Schmidt Pedersen, who has decided to step down from his role and leave LEO Pharma after six years in the company.
Nathalie Daste holds an MBA from INSEAD, France, and a master’s degree in management from ESSEC, France. She is French and will be relocating to Denmark with her family.
Christophe Bourdon, CEO of LEO Pharma, commented:
“I am looking very much forward to welcoming Nathalie Daste to the LEO Pharma family. Her vast experience from global life-science makes her a catch for LEO Pharma as we have been looking for a successor to Dennis Schmidt Pedersen. Nathalie brings a strong external view and experience from developing and leading people to LEO Pharma. With her joining the Global Leadership team, we can ensure these insights are brought into strategy. I would like to thank Dennis for everything he has done for LEO Pharma. We are in a good place today because of him. I wish him all the best of success in his next endeavour.”
Comments powered by CComment